drug design
http://www.yso.fi/onto/yso/p25180
Related publications and other outputs
- Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin (2022) Schiffers, Ingo; et al.; A1
- Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers (2022) Mironov, Vladimir; et al.; A1; OA
- The azulene scaffold from a medicinal chemist's perspective : Physicochemical and in vitro parameters relevant for drug discovery (2022) Leino, Teppo O.; et al.; A1; OA
- The Influence of Tissue Architecture on Drug Response : Anticancer Drug Development in High-Dimensional Combinatorial Microenvironment Platforms (2022) Jokela, Tiina A.; et al.; A3; 978-3-030-98950-7
- Computational cytochrome P450 mediated metabolism and virtual screening (2021) Ahinko, Mira; G5; OA; 978-951-39-8496-0
- A Practical Perspective : The Effect of Ligand Conformers on the Negative Image-Based Screening (2019) Ahinko, Mira; et al.; A1; OA
- Microencapsulation of Enteric Bacteriophages in a pH-Responsive Solid Oral Dosage Formulation Using a Scalable Membrane Emulsification Process (2019) Vinner, Gurinder K.; et al.; A1; OA
- Microencapsulation of Salmonella-Specific Bacteriophage Felix O1 Using Spray-Drying in a pH-Responsive Formulation and Direct Compression Tableting of Powders into a Solid Oral Dosage Form (2019) Vinner, Gurinder K.; et al.; A1; OA
- Suitability of MMGBSA for the selection of correct ligand binding modes from docking results (2019) Ahinko, Mira; et al.; A1; OA
- Discovery of Retinoic Acid-Related Orphan Receptor γt Inverse Agonists via Docking and Negative Image-Based Screening (2018) Rauhamäki, Sanna; et al.; A1; OA